Join to view full profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-471-9200
Fax+1 626-301-8233
Dr. Portnow is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1999 - 2002
Temple University HospitalResidency, Internal Medicine, 1994 - 1997
University of Rochester School of Medicine and DentistryClass of 1994
Certifications & Licensure
CA State Medical License 2002 - 2028
MD State Medical License 1998 - 2003
PA State Medical License 1995 - 1998
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Acute Care, Allscripts, 2013-2017
- CMS Meaningful Use Stage 2 Certification Sunrise Ambulatory Care, Allscripts, 2013-2017
- CMS Meaningful Use Stage 2 Certification Allscripts FollowMyHealth, Allscripts, 2013-2017
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
- High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2005 Jul 12
- Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
Publications & Presentations
PubMed
- Evaluating "brain permeability": A critical issue for the development of therapeutic agents for primary and metastatic brain tumors.Stuart A Grossman, Amy Barone, Roy E Strowd, Rana Rais, Elizabeth Duke
Neuro-Oncology. 2026-07-01 - Coping with primary brain tumors together: a scoping review of dyadic psychosocial interventions.Chiara Acquati, Nenette A Caceres, Karen Clark, Alejandro Fernandez, Jana Portnow
Supportive Care in Cancer. 2026-04-16 - RAGE Inhibition Reduces Surgery-Induced Cerebral Edema After Glioma Resection.Mojtaba Dayyani, Aleksandr Filippov, Ian Zhang, Joseph Georges, Zaan Saeed
Neurosurgery. 2026-03-19
Press Mentions
CAR T-cell Therapy for HER2+ Breast Cancer with CNS MetastasesDecember 30th, 2025- Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
- Calidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade GliomaAugust 2nd, 2022
Grant Support
- Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of VulnerabilityBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2021–2026
- Pilot Feasibility Dose Escalation Study Using Intracerebral MicrodialysisNational Center For Research Resources2009
- A Pharmacokinetic And Pharmacogenomic Study Of Patients With High-GradeNational Center For Research Resources2008–2009
- A Phase I Study Of Bortezomib And Temozolomide In Patients With Refractory SolidNational Center For Research Resources2006–2009
- A Pilot Feasibility Study Of Intracerebral Microdialysis To Determine The NeuroNational Center For Research Resources2007–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
